• Change country/language

    Looks like you’re in {} — you’re on the {} site.

    Cancel

    Country and language selected

    You are being redirected to the {} site. Products and services availability vary by country. Do you wish to continue?

    Continue
    Cancel

Omnipaque™ (iohexol) Resources

approved since 1985, this low-osmolar iodinated contrast media is indicated for intravenous, intra-arterial, intrathecal, intraarticular, body cavity and oral use¹

Omnipaque product family shot-desktop

Content cannot load

Content cannot load

Please try refreshing the page or try again later.

JB01512CA February 2026

Subscribe to Omnipaque™ (iohexol) Resource Updates